Natco Pharma

Rediff.com » News » Natco Pharma

News for Natco Pharma

Business

Mid, small-caps outperform in four years of Narendra Modi government

Analysts attribute this outperformance to the government's proactive economic reform measures Illustration: Uttam Ghosh/Rediff.com Mid-and small-cap indices have outperformed large-caps in the......

5 cos that bucked the note ban gloom

V-Mart, Manaksia, Whirlpool Global and few other companies posted better third-quarter results. This column celebrates companies that defied the demonetisation gloom (‘there will be blood on......

India's FDI during Apr-Feb jumps to $37.53 billion

Services attracted the most FDI during the first eleven months period of 2015-16. Foreign direct investment (FDI) in India increased to $37.53 billion during April-February period of the last......

Bears grip Sensex in FY16; investors poorer by Rs 7 lakh crore

Investor wealth too fell by nearly Rs 7 lakh crore during 2015-16 or over Rs 2,700 crore per trading session. In its worst show in four fiscals, the market benchmark Sensex on Thursday ended......

US Fed rate hike boosts Sensex by 309 points; Nifty ends near 7,850

Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers. Benchmark share indices gained for the fourth straight session tracking a rally in global......

Web results for Natco Pharma

Natco Pharma's comparatively reasonable valuation makes it stock pick of the week

With the fear of the pandemic going away, sales from other divisions are expected to normalise soon. Synopsis Natco’s recent diversification... ...

https://economictimes.indiatimes.com/wealth/invest/natco-pharmas-comparatively-reasonable-valuation-makes-it-stock-pick-of-the-week/articleshow/80421665.cms

Maintaining Growth through Diversification

Posted by Equitymaster The year 2021 has begun on a high note on the news of COVID-19 vaccine rollout. The event holds great importance as it is... ...

http://feeds.equitymaster.com/~r/TheOutsideView/~3/c2IyepNT7Ok/detail.asp

Natco Pharma launches anti blood clot medication, Rivaroxaban, in India

Rivaroxaban is an anticoagulant medication used to treat and prevent blood clots. The medication is currently sold by Bayer under the brand name of... ...

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-launches-anti-blood-clot-medication-rivaroxaban-in-india/articleshow/79779503.cms

Hyderabad-based Natco Pharma wants to make Eli Lilly’s Covid drug

Natco has sought nod for the manufacture and marketing of baricitinib bulk drug and tablets in 1 to 4 mg versions in India. This move may trigger... ...

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-wants-to-make-eli-lillys-covid-drug/articleshow/79671431.cms

NATCO PHARMA Share Price Up by 6%; BSE HEALTHCARE Index Up 1.1%

Posted by Equitymaster NATCO PHARMA share price has zoomed 6% and is presently trading at Rs 971. Meanwhile, the BSE HEALTHCARE Index is at 21,219... ...

http://feeds.equitymaster.com/~r/TodaysMarket/~3/Otd-OG2eiAY/indian-share-markets-updates.asp

See All